Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Dementia01:30

Dementia

702
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
702
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

5.7K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
5.7K
Vascular Spasm01:16

Vascular Spasm

4.8K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.8K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.2K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Selective molecular and network architecture features underlie brain cortical atrophy in dementia with Lewy bodies.

Journal of biomedical science·2026
Same author

The utility of a composite endpoint for tracking disease progression in Lewy body dementia.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

Association between angiotensin receptor blocker use and postmortem dementia pathology: analysis of the UK Brain Banks Network dataset.

BMJ neurology open·2026
Same author

Multicenter development and validation of a probability-based model to diagnose Lewy body disease using ¹²³I-meta-iodobenzylguanidine.

European journal of nuclear medicine and molecular imaging·2026
Same author

Progression of clinical diagnostic features and cognitive decline in mild cognitive impairment with Lewy bodies.

Psychological medicine·2025
Same author

Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder.

EBioMedicine·2025

関連する実験動画

Updated: Mar 29, 2026

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
04:29

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

1.3K

血管性認知症

John T O'Brien1, Alan Thomas2

  • 1Department of Psychiatry, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Lancet (London, England)
|November 24, 2015
PubMed
まとめ

認知機能低下の一般的な原因である血管性認知症は 分類の問題とアルツハイマー病の不明確な関連性のために 承認された治療法がありません 有効な血管性認知症管理戦略を開発するには,さらなる研究が不可欠です.

科学分野:

  • 神経学
  • 神経科学
  • 高齢者医療

背景:

  • 血管性認知症は 認知症の2番目に多いタイプで 患者の15%を占めています
  • アルツハイマー病とは異なり,血管性認知症には現在認可された治療法はありません.
  • 診断の不確実性や 脳血管の問題と 認知機能の低下の間の不明確な関係が 課題です

研究 の 目的:

  • 血管性認知症の研究における重要な分野と論争を批判する.
  • 血管性認知症の 既存の治療試験を要約します
  • 病原性を理解し,新しい治療法を開発するために必要な進歩を提案する.

主な方法:

  • 血管性認知症に関する既存の研究の文献レビューと批判的分析.
  • 過去の臨床試験と現在進行中の臨床試験のデータをまとめました.
  • 知識のギャップと将来の研究方向の特定

主要な成果:

  • 分類の曖昧さや明確な治療目標の欠如により,進歩が妨げられています.
  • 血管病理とアルツハイマー病の病理のメカニズム的な関連は不明である.
  • 現在の治療試験は限られた成功を収めている.

さらに関連する動画

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.5K
A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

1.6K

関連する実験動画

Last Updated: Mar 29, 2026

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
04:29

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

1.3K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.5K
A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

1.6K

結論:

  • 血管疾患とアルツハイマー病の 相互作用を理解することが重要です
  • 治療可能な標的を特定することは 血管性認知症の管理を進めるために不可欠です
  • 将来の研究は,治療戦略を改善するために病原性を明らかにすることに焦点を当てるべきです.